Cargando…
Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature of prostate tumors as well as cell-type heterogen...
Autores principales: | Jia, Zhenyu, Rahmatpanah, Farah B., Chen, Xin, Lernhardt, Waldemar, Wang, Yipeng, Xia, Xiao-Qin, Sawyers, Anne, Sutton, Manuel, McClelland, Michael, Mercola, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411675/ https://www.ncbi.nlm.nih.gov/pubmed/22870216 http://dx.doi.org/10.1371/journal.pone.0041371 |
Ejemplares similares
-
Correction: Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
por: Jia, Zhenyu, et al.
Publicado: (2012) -
The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma
por: Chen, Xin, et al.
Publicado: (2015) -
Role of the Adjacent Stroma Cells in Prostate Cancer Development and Progression: Synergy between TGF-β and IGF Signaling
por: Lee, Chung, et al.
Publicado: (2014) -
An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account
por: Chen, Xin, et al.
Publicado: (2012) -
RNA expression differences in prostate tumors and tumor-adjacent stroma between Black and White Americans
por: Rahmatpanah, Farah, et al.
Publicado: (2021)